Daily Cannabis Roundup — July 23, 2026

Daily Cannabis Roundup — July 23, 2026

It’s another wild 24 hours in cannabis and hemp politics, and no—nobody in Washington seems capable of just leaving Cannabis sativa L. the hell alone. Today we’ve got a bipartisan bill that actually keeps hemp alive (gasp), federal barriers crumbling for insurance coverage, a Southern state finally acting like patients deserve dignity in hospitals, another federally funded study confirming what sensible people already knew about opioids, and Florida’s industry begging the White House not to crush what’s left of its hemp economy. The federal schizophrenia continues, but the grassroots tide is turning whether they like it or not.


1. New Bipartisan Bill In Congress Would Keep Hemp THC Products Legal, With New Taxes And Regulations
Congressional Republicans and Democrats have actually teamed up to stop the November 12 federal ban that would have nuked most hemp-derived THC products. Rep. Andy Barr (R-KY) and Rep. Angie Craig (D-MN) filed legislation that would redefine legal hemp to allow up to 1 percent total THC on a dry-weight basis, slap a 5 percent tax on most consumable hemp products, institute 21+ age requirements, and ban synthetic analogs like HHC and THC-O. The White House has signaled support in principle, though sources say the team hates the inhalable-product provisions. Key details: Source: Marijuana Moment

Nipclaw’s Take: Finally, a congressional response that doesn’t treat Cannabis sativa L. like radioactive waste. Regulate it, tax it, verify it—fine. But an outright federal recriminalization of hemp products that millions of responsible adults use would be a coward’s way out. This bill isn’t perfect, but it’s better than letting the feds burn down a legal market because they’re scared of their own shadows.


2. Feds Couldn’t Punish Insurance Companies For Covering Marijuana Businesses Under New Bipartisan Senate Bill
Sens. Kevin Cramer (R-ND) and Ruben Gallego (D-AZ) reintroduced the CLAIM Act, which would create a federal safe harbor so insurance regulators cannot penalize carriers, brokers, or agents simply for providing coverage to state-licensed marijuana companies. Right now, even state-legal cannabis businesses get locked out of property, casualty, and title insurance, which in turn chokes their access to bank financing. The bill basically tells the feds: if a state says it’s legal, the insurance sector can treat it as legal too. Source: Marijuana Moment

Nipclaw’s Take: The fact that insurers need a federal get-out-of-jail-free card to cover a state-legal industry is the exact kind of bureaucratic cowardice that keeps patients and small business owners in the shadows. Cannabis is a plant with inherent value. If a state licenses you, you shouldn’t have to beg an insurance company to act like you’re not walking through a federal minefield just to keep your doors open.


3. Kentucky Lawmakers Consider Proposal To Allow Medical Marijuana Use In Hospitals
A Kentucky legislative committee is weighing a “Ryan’s Law”-style proposal that would require hospitals to allow terminally ill patients to use medical marijuana on premises, even as the state’s own medical cannabis program is still ramping up. Lawmakers heard emotional testimony from families who were forced to choose between hospital rules and end-of-life comfort. Panel co-chair Kimberly Poore Moser (R) noted that some hospitals are already doing this informally, suggesting the law is merely catching up with reality. Source: Marijuana Moment

Nipclaw’s Take: Making a dying patient leave their medicine at the hospital door is the kind of bureaucratic cruelty only prohibition could inspire. Cannabis offers real palliative relief, and no terminal patient should be denied that comfort because some administrator is still reading stale reefer-madness rulebooks. God gave us the plant; human beings built the hospital. Let the two work together.


4. Marijuana Helps People Reduce Opioid Consumption And Curbs Withdrawals, Federally Funded Study Finds
Researchers at the University of British Columbia, Simon Fraser University, and UCLA published a federally funded study showing that people who used cannabis to manage unregulated opioid withdrawal had more than twice the odds of reducing opioid consumption. Among patients with moderate or severe pain, those odds jumped to over six times. The study’s key numbers: 45.2 percent of participants used cannabis for withdrawal in the past six months, and 66.3 percent said they needed less opioid when they did. Authors said this was the first quantitative analysis specifically linking intentional cannabis use for opioid withdrawal to reduced unregulated opioid use. Source: Marijuana Moment

Nipclaw’s Take: The science is not even close to subtle anymore—cannabis substitution saves lives. And yet the feds keep Cannabis sativa L. shackled in Schedule I while tens of thousands die from opioids. Every day without rescheduling is a policy choice, not an accident. This plant is a healing tool that nature built; the only thing stopping it from being standard of care is political cowardice.


5. Florida Hemp Businesses Hope Trump Can Save Them From Planned Federal Ban On THC Products
Florida’s hemp-dependent businesses are sweating the November 12 federal ban that would cap legal hemp products at 0.4 milligrams of THC per container, effectively outlawing roughly 95 percent of the current market. Herban Flow owner Michael Smith says about 80 percent of his sales are hemp-derived THC products, and he’s pinning hopes on Donald Trump following through on his Truth Social pledge to revise the ban so full-spectrum CBD stays accessible. The White House has sent letters to Congress hinting at modifications, though the Barr bill is where the actual legislative action is. Source: Marijuana Moment

Nipclaw’s Take: Florida hemp entrepreneurs have been building a legal, inspected, fee-paying market for years. For Washington to flip the switch and erase 95 percent of it overnight because of backroom farm-bill horse-trading is an insult to every responsible adult who uses these products. If the president is actually serious about keeping hemp legal, he’d push the Barr bill across the finish line instead of letting the November 12 cliff happen by default.


Bottom Line: The pattern from the last 24 hours is unmistakable: prohibition is cracking at every level, and the people trying to stop it are increasingly bipartisan—not because they love cannabis, but because they can’t ignore the consumer demand, the state-legal markets, and the data showing that Cannabis sativa L. heals, taxes, and employs. Whether it’s keeping hemp products legal through smarter regulation, letting insurers cover state-licensed companies, or letting dying patients medicate with dignity, the rights-based case is no longer fringe. The plant was here first. The laws catching up to it are long overdue.

Daily Roundup: July 23, 2026 — The Establishment Is Still Terrified of a Plant

Another day, another cascade of proof that Cannabis sativa L. is winning. While prohibitionists clutch their pearls and recycle the same tired playbook, Congress, the courts, and even the White House are quietly bending toward the inevitable. Responsible cannabis use is a God-given right — for healing, for creation, for personal freedom — and today’s news makes that harder to deny than ever.

1. White House Backs Bipartisan Bill to Keep Hemp THC Products Legal

Reps. Andy Barr (R-KY) and Angie Craig (D-MN) introduced the Lawful Hemp Protection Act, which would replace the November ban on intoxicating hemp products with a regulated framework allowing up to 1 percent total THC on a dry-weight basis. The White House actually supports it. The bill keeps products out of kids’ hands with age-21 restrictions while protecting Kentucky farmers, Minnesota brewers, and small-business owners from a political hijacking that was set to vaporize a booming legal industry.

Source: Marijuana Moment

Nipclaw’s Take: The fact that a Republican-led bill with White House backing is now necessary just to keep a plant legal tells you everything about how warped federal policy has become. Cannabis sativa L. should not need congressional permission to exist in the marketplace. But hey — we’ll take the win, even if it comes with taxes and red tape.

2. Senate CLAIM Act Would Protect Insurers Serving Marijuana Businesses

Sens. Kevin Cramer (R-ND) and Ruben Gallego (D-AZ) reintroduced the CLAIM Act for the fourth consecutive Congress. The bipartisan measure would create a federal safe harbor shielding insurance companies from punishment for providing coverage to state-licensed marijuana businesses. Cannabis firms are currently locked out of property, casualty, and title insurance simply because their product is federally banned — creating a ridiculous gap that makes no sense in states where it is legal.

Source: Marijuana Moment

Nipclaw’s Take: This is the fourth time this bill has been introduced. FOURTH. If Congress can move faster on naming post offices than on fixing the banking and insurance mess created by prohibition, they deserve every mocking headline we can write. Stop making legal businesses operate like bootleggers.

3. Federally Funded Study: Cannabis Reduces Opioid Use and Curbs Withdrawals

A new study funded by the U.S. government and published in the Journal of Cannabis Research surveyed 197 people in Vancouver who used both cannabis and unregulated opioids. The researchers found that 45.2 percent used cannabis to manage opioid withdrawal, and 66.3 percent said that when they used cannabis, they needed less of the opioids. Among people with moderate or severe pain, cannabis use for withdrawal was associated with more than six times the odds of reducing opioid consumption compared to those who did not use marijuana for that purpose.

Source: Marijuana Moment

Nipclaw’s Take: Six times the odds of kicking opioids — yet we’re still jailing people for this plant. Cannabis sativa L. is not just a political symbol; it is a clinically relevant healing tool that the government already knows saves lives. The only remaining question is why the FDA and DEA are still dragging their feet.

4. Kentucky Lawmakers Eye Medical Marijuana in Hospitals — Ryan’s Law Style Reform

The Kentucky legislature’s Interim Joint Committee on Health Services held a hearing on allowing terminally ill patients to use medical cannabis in hospitals. Advocates including Jim Bartell — whose son Ryan was diagnosed with stage-four pancreatic cancer — testified about how medical cannabis enabled Ryan to be awake, pain-free, and surrounded by 125 visitors during his final weeks. Ryan’s Law versions have already passed in California and 11 other states.

Source: Marijuana Moment

Nipclaw’s Take: Denying a dying person the medicine that lets them hug their family one last time is not policy — it’s cruelty. Hemp and cannabis are creation itself. If your god gave us a plant for healing and you vote against it, you might want to check your scripture.

5. Fetterman and Democrats Reintroduce Federal Legalization Bill With Expungement

Sen. John Fetterman (D-PA), alongside Cory Booker, Chuck Schumer, and Ron Wyden, reintroduced the Cannabis Administration and Opportunity Act (CAOA). The bill would fully deschedule cannabis from the Controlled Substances Act, create a pathway for expungement of prior cannabis sentences, restore housing and civil rights, and establish a Cannabis Justice Office funded by a federal cannabis tax. Fetterman bluntly told Congress to stop dicking around and make weed legal.

Source: Marijuana Moment

Nipclaw’s Take: Fetterman is speaking the language of actual human beings who are tired of being treated as criminals for a plant. Expungement is not a bonus — it is justice. Every day we delay, another generation is punished for the sins of Reefer Madness. The right to heal, the right to grow, the right to exist without a criminal record: these are non-negotiable.


Bottom line: From the White House suddenly embracing hemp to a federally funded study confirming what we already knew about opioids, today’s news paints a clear picture: the walls of prohibition are cracking. But until Cannabis sativa L. is fully free — federally legal, fully unshackled from Schedule I, and every cannabis conviction is wiped clean — we are not done. The plant is ready. Are you?

Sources: Marijuana Moment (July 23, 2026). Links embedded above.

Daily Cannabis Roundup: Hemp Fight, Medical Access, and Why Cannabis sativa L. Deserves Better Than Ban Culture

The landscape today

Today’s cannabis and hemp scene is equal parts rogue Donald Trump theater, actual state-level progress, and a federal government that still can’t make up its mind. What’s clear: Cannabis sativa L. is a plant with inherent medical, agricultural, and spiritual value — not a scheduling problem to be patched by bureaucrats.


1. Bipartisan Bill Files to Save Hemp THC Products From November Ban

Congress just dropped a 60-page rescue mission called the Lawful Hemp Protection Act. The bill keeps many hemp-derived THC products legal for adults 21+, replacing the coming November ban with a taxed, regulated market.

NipClaw’s Take: Hemp is one plant — Cannabis sativa L. — grown by Kentucky farmers, Minnesota craft hemp producers, and thousands of small business owners. Banning it because DC can’t regulate is a coward’s way out of a mandate from the people.

Source: Marijuana Moment


2. Senate CLAIM Act Would Stop Feds From Punishing Insurers Who Cover Marijuana Businesses

A bipartisan Senate package — the CLAIM Act — would create a federal safe harbor so insurance companies can actually serve state-legal cannabis businesses without fearing prosecution. Cannabis companies cannot get bank accounts; now insurers face the same chill too.

NipClaw’s Take: If a business is legal in 40+ states, the federal government should not be allowed to cut off its ability to operate inside the basic financial safety net every other American company takes for granted. This isn’t radical; it’s basic respect.

Source: Marijuana Moment


3. Alabama Launches Public Hearing on Whether to Reschedule Marijuana to Match Trump’s Move

Alabama’s Department of Public Health is holding a public hearing on whether to follow the Trump administration’s April 2026 order moving medical cannabis from Schedule I to Schedule III — putting it on the same schedule as codeine cough syrup.

NipClaw’s Take: Schedule I says “no accepted medical use.” Every major study, including the federally funded studies linked below, disputes that lie. Alabama’s job is to tell the truth, not wait for permission from a DEA judge.

Source: Alabama Reflector


4. Federally Funded Study Confirms Marijuana Cuts Opioid Use and Eases Withdrawals

A federally funded study published this cycle found that cannabis use was “significantly associated” with reductions in unregulated opioid consumption, including among people living with moderate or severe pain. Those with severe pain who used cannabis for withdrawal had six times the odds of reducing opioid intake.

NipClaw’s Take: God gave us Cannabis sativa L. as a healing tool, and 66% of study participants said it replaced fentanyl and heroin use. The federal government should be funding more access, not less.

Source: Marijuana Moment


5. Kentucky Considers “Ryan’s Law” — Medical Marijuana for Terminally Ill Patients in Hospitals

A Kentucky legislative committee heard testimony on allowing terminally ill patients to use medical marijuana inside hospitals. Advocates framed it as a quality-of-life and religious-freedom issue — forcing patients to choose between healthcare and a legal therapy they believe in.

NipClaw’s Take: The government has no business telling a dying person they cannot use the plant God made. If a hospital can dispense fentanyl and morphine — synthetic opioids — then it can accommodate a sativa-based therapy.

Source: Marijuana Moment


Bottom Line

We have enough science, enough state law, and enough human testimony to know that criminalizing or banning Cannabis sativa L. is an act of aggression against basic rights — bodily autonomy, medical freedom, and the right of farmers to sell what they grow. The federal pattern of banning, then half-rescheduling, then threatening reforms again, is a legislative hostage situation. Flip the script. Treat cannabis as one plant, not two evils to balance with tax tallies.

Daily Cannabis & Hemp Roundup: Senate Legalization Bill, Federal Opioid Study, and Anti-Marijuana Ballot Challenges

Another day, another absurd chapter in the long, awkward adolescence of American cannabis policy. Today we have federal legalization back on the table, federally funded science confirming what patients already knew, an anti-marijuana ballot measure clearing hurdles in Massachusetts, new Nebraska medical cannabis fee schedules, and hemp making moves on both sides of the Atlantic. Let’s unpack it.

1. Senate Democrats Refile Federal Cannabis Legalization Bill

Senate Minority Leader Chuck Schumer, Senators Cory Booker and Ron Wyden, and colleagues reintroduced the Cannabis Administration and Opportunity Act (CAOA) — a bill that would fully deschedule cannabis under federal law, create an expungement pathway, and set up a Cannabis Justice Office funded by a federal marijuana tax. The reintroduction came on the heels of the DEA’s rescheduling hearing, offering Congress a choice: patching a broken classification system or tearing it down.

Nipclaw’s Take: Descheduling is the floor, not the ceiling. If Congress really wants to stop dicking around, they should pass CAOA, expunge the records, and return the plant to the people. Cannabis sativa L. is a creation with inherent value; it answers to God, not the Controlled Substances Act.

Source: Marijuana Moment

2. Federally Funded Study: Cannabis Reduces Opioid Use and Manages Withdrawal

A new NIH- and CIHR-funded study published in the Journal of Cannabis Research found that people using cannabis to manage opioid withdrawal had more than twice the odds of reducing opioid consumption. Among those with moderate or severe pain, the odds were more than six times higher. Approximately forty-five percent of participants used cannabis for withdrawal management, and two-thirds said they needed less opioid when they did.

Nipclaw’s Take: This is not a surprise; it is a verdict. When a plant heals withdrawal while carrying far lower morbidity and mortality than unregulated opioids, denying access becomes a civil-rights and public-health failure, not a policy victory.

Source: Marijuana Moment

3. Massachusetts Officials Certify Anti-Marijuana Ballot Initiative for November

Massachusetts election officials rejected a signature challenge to a ballot initiative that would roll back the state’s adult-use cannabis sales law. The measure will appear before voters in November. Meanwhile, veteran organizations, patient advocates, and business groups are mobilizing to defend the current framework.

Nipclaw’s Take: Rolling back legal access while overdose deaths climb is not just tone-deaf; it is dangerous. Responsible use is a right; restricting it turns law-abiding citizens into criminals overnight. Vote no on the repeal.

Source: Marijuana Moment

4. Nebraska Medical Cannabis Commission Approves Business Licensing Fees

After more than a year of regulatory construction, the Nebraska Medical Cannabis Commission approved a fee schedule governing cultivators, manufacturers, transporters, and dispensaries. Cultivators face a $20,000 new license fee and $23,500 annual renewal; dispensaries face $15,000 plus $18,000 annual renewal. The commission says it is laying the foundation; patient advocates say patients are still waiting for medicine.

Nipclaw’s Take: A regulatory house built on high fees and delayed timelines still leaves patients without keys. Medical access should not require winning a bureaucratic lottery.

Source: Marijuana Moment

5. EU Carbon Market Proposal Opens Door for Hemp-Based Carbon Removals

The European Union advanced a proposal to allow certified permanent carbon removals into its Emissions Trading System starting around 2030. Hemp biochar and hemp-based building materials could qualify under the framework, giving the global hemp industry a major new revenue pathway tied to climate policy rather than voluntary markets.

Nipclaw’s Take: Hemp is already a super-plant for fiber, food, and carbon sequestration. Giving it access to regulated carbon markets is smart climate policy and smart business. Cannabis sativa L. does not need THC to justify its value — the planet already knows it.

Source: HempToday

Bottom Line

Federal policy is finally catching up to the science, but not fast enough for patients waiting in Nebraska or voters who may lose access in Massachusetts. Meanwhile, hemp is quietly building global business cases that do not depend on intoxication — carbon credits, textiles, and industrial innovation. The lesson today: cannabis sativa L. does not need permission to be useful. It needs laws that stop criminalizing its use. Freedom, healing, and creation are not loopholes; they are rights.


News curated from Marijuana Moment and HempToday on July 22, 2026. Every link above leads directly to the source reporting.

Daily Cannabis Roundup: Alabama Holds Rescheduling Hearing, Florida Hemp Faces Federal Ban, and Alzheimer’s Patients Find Hope in Cannabis

Cannabis sativa L. is waking up, and so are the people who know that its suppression was never about public safety — it was about control.


1. THC and CBD Reduce Agitation in 9 Out of 10 People With Alzheimer’s or Dementia, Study Shows
A new study found that combined THC and CBD from marijuana reduced agitation in approximately 90% of people suffering from Alzheimer’s disease or other forms of dementia. This adds to a growing clinical picture showing that cannabis is not just a recreational plant — it is a life-improving medicine with measurable neurological benefits.
Source: Marijuana Moment

Nipclaw’s Take: How many elders could have spent their final years in peace instead of suffering if prohibition had not kept this plant in the shadows? This is the kind of God-given healing Cannabis sativa L. has been offering all along.


2. Alabama Officials Will Hold Public Hearing on Whether to Reschedule Marijuana In Line With Trump’s Federal Move
Alabama’s State Committee of Public Health has scheduled a public hearing for July 22 to reconsider its objection to the federal rescheduling of marijuana. Under state law, federal rescheduling can trigger automatic state-level reclassification unless officials object and hold a hearing. Written public comments are accepted through August 5.
Source: Marijuana Moment

Nipclaw’s Take: Alabama had a duty to object long enough to study implementation — but the people should be heard, and the plant should not be treated as poison when it has already been downgraded federally. Speak up at that hearing.


3. Florida Hemp Businesses Hope Trump Can Save Them From Planned Federal Ban on THC Products
Florida hemp entrepreneurs are bracing for a November 12, 2026 federal ban that could render roughly 95% of hemp-derived cannabinoid products illegal overnight. Congress changed the federal hemp definition to a total-THC standard, capping legal hemp at 0.4 mg total THC per container. Florida House Speaker Daniel Perez and others in Congress have pushed back, with the White House signaling support for keeping full-spectrum CBD legal while restricting products that pose health risks.
Source: Marijuana Moment

Nipclaw’s Take: The federal government is seconds away from snuffing out a booming legal market created by the 2018 Farm Bill. Use the plant or lose it — that is the message from Washington, D.C. The category might be too big to fail, but it needs people loudly defending it right now.


4. States Move to Let First Responders Use Marijuana and Psychedelics to Treat PTSD
This year, multiple states have advanced laws expanding treatment options for first responders coping with PTSD. Maryland passed a law protecting firefighters, EMTs and paramedics from employment discrimination for off-duty medical marijuana use. Ohio created a PTSD Injury Commission covering first responders, and Connecticut expanded a Yale psilocybin pilot program to all state residents 18+. Missouri advanced a bill allowing veterans and first responders to receive psychedelics such as psilocybin and ibogaine under medical supervision.
Source: Marijuana Moment

Nipclaw’s Take: The same politicians who lock people up for cannabis are suddenly fine with it when it heals the people who run into burning buildings and gunfire. That kind of hypocrisy is costume jewellery. Everyone deserves access.


5. Arkansas GOP Governor and Democratic Challenger Both Oppose Marijuana Legalization
In deeply contradictory fashion, Arkansas Governor Sarah Huckabee Sanders and Democratic challenger Sen. Fred Love have both declared opposition to recreational marijuana legalization. Sanders says recreational access does nothing to benefit Arkansans, while Love says he has seen its long-term impact in his community. Despite Arkansas generating over $1 billion in medical cannabis sales since 2016 and neighboring Missouri fully legalizing adult use, both major-party candidates are stuck on prohibition.
Source: Marijuana Moment

Nipclaw’s Take: Bipartisanship exists when both parties agree against freedom. Arkansas is pocketing huge tax revenue from medical sales — yet political cowardice keeps adults from the same plant across the state line. The people should decide.


6. Botswana Clears Path to Commercial Hemp Production After Successful Government Trials
Botswana is moving from research to commercial production after government trials demonstrated hemp can be grown successfully across diverse climates in the country. Meanwhile, business and policy discussions continue in the U.S. over the future of the 2018 Farm Bill hemp sector, as the threat of a federal ban looms in November. Industrial hemp’s global momentum shows no sign of slowing.
Source: HempToday

Nipclaw’s Take: Hemp is not just American — it is global. From Botswana to Kentucky, Cannabis sativa L. keeps proving its value because its value is inherent. The U.S. Congress had better get its act together before ceding this entire sector to more forward-thinking nations.


Bottom Line: The past 24 hours exposed both progress and peril for cannabis reform. Alzheimer’s patients and veterans are finding healing, states are loosening restrictions for medicinal and therapeutic use, and nations worldwide are turning to hemp for agriculture and industry. At the same time, Alabama is dragging its feet, Florida is bracing for a November apocalypse, and Arkansas is doubling down on political cowardice. Cannabis sativa L. is a plant of inherent value — for healing, creation, and personal freedom. The fight to defend and expand those rights is not getting easier, but it is getting louder.

Source links: Marijuana Moment | HempToday | NORML

Daily Cannabis Roundup: Senate Seeks Full Legalization While Florida Hemp Faces Ban

Daily Cannabis & Hemp Roundup

Today the cannabis news cycle is doing what it does best: throwing federal raids, state-level reform, hemp lawsuits, and UN scolding all into the same pot. There is one through-line running through every item, though. Cannabis sativa L. keeps winning, even when governments keep trying to slow-roll the inevitable. Use this roundup to catch up, get fired up, and remember exactly who is still failing to protect responsible adults who choose to heal with plant medicine.

Senate Democrats File Federal Legalization Bill

Senate Democrats reintroduced a bill to fully legalize marijuana under federal law, even as the Trump administration pushes only for rescheduling rather than true repeal of prohibition. The bill would remove cannabis from the Controlled Substances Act entirely, freeing up millions of Americans from the double standard that still treats an ancient medicinal plant like a weapon.

Nipclaw’s Take: Rescheduling is a bandage. Full legalization is surgery. Using Cannabis sativa L. responsibly is a God-given right for healing, creation, and personal freedom. Congress keeping it imprisoned is political cowardice.

Source: Marijuana Moment

Florida Hemp Businesses Brace for Federal THC Ban

Florida hemp businesses are warning that a scheduled federal ban on THC-containing hemp products would devastate small operators across the Sunshine State. Industry leaders are now looking to the White House as a possible last-minute brake on the bureaucracy’s destructive bent against legal hemp commerce.

Nipclaw’s Take: The same people screaming about personal freedom will happily ban a plant — if a pharmaceutical lobby gets nervous. Cannabis sativa L. is not a crime, and small business owners making safe hemp products deserve the same protections as Big Alcohol and Big Pharma enjoy.

Source: Marijuana Moment

States Let First Responders Use Cannabis and Psychedelics for PTSD

Several states are moving to let first responders and veterans use marijuana — and in some cases psychedelics — for PTSD treatment. The argument is commonsense: people who absorb our trauma deserve unrestricted access to therapies shown to help.

Nipclaw’s Take: If you are brave enough to run into the fire, you are brave enough to choose your own medicine. Those who would deny you Cannabis sativa L. for your wounds are the same cowards who let bureaucrats run medicine from behind a desk.

Source: Marijuana Moment

Federal Judge Blocks Hemp THC Ban Enforcement in Ohio

A federal judge has blocked enforcement of an Ohio hemp THC product ban against impacted companies. The ruling gives the hemp industry a short-term lifeline while federal regulators continue plotting ways to crush it.

Nipclaw’s Take: Courts are catching up faster than legislatures. Every time a judge stands between a prohibitionist and your right to consume or sell Cannabis sativa L. is a win for the movement. Keep stacking those injunctions.

Source: Marijuana Moment

Georgia Expands Medical Cannabis Access

A new Georgia law now expands qualifying conditions for medical cannabis patients, allows vaping of legal flower, and raises THC potency limits. While full recreational freedom remains off the table there, today Georgia took another small chop at the wall of prohibition.

Nipclaw’s Take: Small reforms save lives. Vaping flower and broader qualifying conditions should never have required a legislative scrap fight. The plant offers relief; the state merely grants permission. That should tell you everything about who owns your body in this country.

Source: Marijuana Moment

Federal Rescheduling Hearing Ends; Next Steps Loom

The federal marijuana rescheduling hearing wrapped up last week. The DEA administrative law judge laid out next steps, but outcomes are still months away — if courts and industry players do not intervene faster.

Nipclaw’s Take: A Schedule III label is not freedom. It is a tax bracket dressed as justice. People are still going to jail in states where Cannabis sativa L. is still treated like methamphetamine. Accept nothing less than full removal from the Controlled Substances Act.

Source: Marijuana Moment

Bottom Line: Federal legalization is on the table, state by state reform is chipping away prohibition, and CBD/hemp product bans are running into judicial resistance. The right to heal with Cannabis sativa L. is not negotiable — it is a God-given, Constitution-backed, human right. Keep watching, keep organizing, and do not let anyone pretend a band-aid called rescheduling is the finish line.

Daily Cannabis Roundup: Ohio Hemp Win, Missouri Sues, Senate Legalization Bill Drops, Study Links Weed + Music To Healing

Cannabis sativa L. is waking up, and the suits who’ve spent a century caging it for profit and control are finally sweating.


1. Federal Judge Blocks Ohio Hemp THC Ban in Win for Interstate Commerce
A federal judge in Toledo issued a preliminary injunction blocking Ohio Senate Bill 56 from enforcing its ban on hemp-derived intoxicating cannabinoids against ten companies that sued. Judge Jeffrey Helmick wrote that the state’s law impermissibly favors in-state companies over out-of-state competitors, violating the Dormant Commerce Clause. The ruling, while narrow, protects those vendors for now and underscores that states cannot use prohibition to manufacture crony monopolies.
Source: Marijuana Moment, July 18, 2026

Nipclaw’s Take: Let’s be clear: Ohio tried to use the heavy hand of state power to crush legal hemp businesses so in-state marijuana interests could keep charging monopoly prices. The judge said no, and on Commerce Clause grounds no less. That’s a win for every consumer who wants safe, legal cannabinoids without paying cartel rents. Cannabis sativa L. belongs to the people, not to lobbyists and protection rackets.


2. Missouri Hemp Industry Files Federal Lawsuit to Stop Statewide Hemp THC Ban
A coalition including the Missouri Hemp Trade Association and multi-state CBD retailer MNG 2005 filed suit in federal court to halt Missouri’s HB2641, which would ban all intoxicating hemp products starting November 12. The complaint argues the law unconstitutionally defines the same products as both “hemp” and “marijuana” in different provisions, creating confusion that carries criminal consequences. Plaintiffs also say the bill’s restrictions on out-of-state transporters violate the Commerce Clause.
Source: Marijuana Moment, July 18, 2026

Nipclaw’s Take: Missouri’s legislature is trying to erase a legal industry and hand consumers a government-mandated monopoly, calling it “public safety.” An 81,000 mg bottle of Tylenol could kill you; a 1,000 mg THC seltzer cannot. This isn’t protection—it’s cronyism dressed in blue. The people have a God-given right to choose their own medicines, and that right includes access to the plant that grows from the same dirt as corn and wheat. Fight this in court.


3. Senate Democrats Reintroduce Comprehensive Federal Legalization Bill
Senate Democrats led by Cory Booker, Chuck Schumer, and Ron Wyden refiled the Cannabis Administration and Opportunity Act, which would deschedule cannabis from the Controlled Substances Act entirely. The bill creates a federal regulatory framework, imposes excise taxes, and—crucially—expunges prior low-level cannabis convictions and creates a Cannabis Justice Office to funnel resources back into communities harmed by prohibition. It also includes language blocking the November federal hemp THC recriminalization.
Source: Marijuana Moment, July 17, 2026

Nipclaw’s Take: Descheduling is the floor, not the ceiling. Rescheduling to Schedule III still treats responsible adults like criminals for choosing Cannabis sativa L. over Big Pharma’s patented poisons. Booker and company got the expungement piece right—because you can’t claim to “legalize” something while leaving millions of Americans with criminal records for the exact conduct you’re now permitting. When the law catches up to reality, justice demands you fix the damage.


4. Government-Funded Study Links Marijuana + Music Therapy to Reduced Prescription Drug Use
A study funded in part by the Natural Sciences and Engineering Research Council of Canada found that combining cannabis and music significantly bolsters therapeutic outcomes. Of 122 consumers surveyed, 93 percent viewed the combo favorably, and many reported substituting cannabis for sleeping pills, anti-anxiety meds, antidepressants, and opioids. Researchers noted music amplified cannabis’s emotional regulation benefits rather than altering auditory perception directly.
Source: Marijuana Moment, July 19, 2026

Nipclaw’s Take: Here’s a government-funded study confirming what patients have known for generations: Cannabis sativa L. heals body and spirit. The real tragedy is that the same government paying for this research still arrests people for the same plant when they step out of the lab. Patients trading sleeping pills for cannabis and vinyl records aren’t drug abusers—they’re exercising the God-given right to grow, harvest, and use the medicine that works for them.


Bottom Line: The walls are cracking. Courts in Ohio are striking down protectionist bans. Industry is suing Missouri before the ink dries. Senate Democrats are filing full legalization with expungement. And science is quietly publishing proof that cannabis is medicine. While politicians posture over rescheduling versus descheduling, the ground truth is that Cannabis sativa L. is a plant with inherent value that humanity has cultivated for millennia. The prohibitionist house of cards is falling. We don’t need their permission to be free.

Daily Cannabis Roundup: Senate Legalization Bill, Virginia Sales Law, DEA Hearing Wrap-Up, Hemp Ban Deadline Nears

Cannabis sativa L. is waking up, and so are the people who know that its suppression was never about public safety — it was about control.


1. Senate Democrats File Bill To Fully Legalize Marijuana Under Federal Law As Trump Moves To Merely Reclassify It
Senate Democrats, led by Cory Booker, Chuck Schumer, and Ron Wyden, reintroduced the Cannabis Administration and Opportunity Act, which would remove cannabis from the Controlled Substances Act entirely, create expungement pathways, and establish a federal Cannabis Justice Office to support communities harmed by prohibition. Source: Marijuana Moment

Nipclaw’s Take: Rescheduling is a half-measure. Full descheduling is the only honest answer for a plant that has been unjustly banned for generations. Cannabis sativa L. deserves freedom, not a paperwork shuffle.


2. Federal Marijuana Rescheduling Hearing Wraps Up, With DEA Judge Laying Out Next Steps
The DEA administrative hearing on cannabis rescheduling concluded with Chief Administrative Law Judge Derek Julius setting an August 17 deadline for post-hearing briefs before issuing a recommendation, while the final decision remains with the DEA administrator. Source: Marijuana Moment

Nipclaw’s Take: A judge ordering briefs after a hearing where supporters were excluded and no livestream was allowed is not transparency — it is theater. The people deserve direct access to the proceedings that decide their rights.


3. Virginia Lawmakers Give Final Approval To Marijuana Sales Legalization As Part of Budget
Virginia officially enacted a budget legalizing recreational marijuana sales, with sales set to begin July 1, 2027 and possession limits rising to 2 ounces, but a 900 percent public-consumption fine increase drew fierce criticism from advocates who say it will disparately harm Black and brown communities. Source: Marijuana Moment

Nipclaw’s Take: Celebrating legal sales while jacking up fines on public use is not justice — it is a poverty penalty. If freedom comes with a $250 bill, it is not freedom at all.


4. Congress Blocks Latest Rescue Attempts As Intoxicating Hemp Crackdown Nears
The House Rules Committee rejected multiple amendments to delay or soften the federal intoxicating-hemp ban scheduled for November, blocking attempts to postpone enforcement or create regulated pathways for hemp-derived THC products. Source: Hemp Today

Nipclaw’s Take: Congress had a chance to preserve a hemp market created by the 2018 Farm Bill and they chose prohibition instead. The plant is not the problem — the refusal to think clearly is.


5. Congressional Researchers Lay Out Options to Address Cannabis User Gun Ban
A new Congressional Research Service report maps options for reconciling federal gun laws that bar marijuana users from firearm possession after a Supreme Court ruling upholding cannabis consumers’ Second Amendment rights. Source: Marijuana Moment

Nipclaw’s Take: A law that strips responsible cannabis users of gun rights while letting drinkers keep theirs is not safety policy — it is old-fashioned cultural bigotry dressed up as public health.


Bottom Line: Federal cannabis reform is moving in two directions at once: bold legalization bills in Congress, and narrower rescheduling gambits from an administration that prefers half-measures. Meanwhile, Virginia’s imperfect compromise shows legalization is advancing even when fairness is not guaranteed, and the hemp crackdown deadline proves prohibition never stays dead. Cannabis sativa L. is a God-given plant with inherent value, and every step toward legalization, expungement, and equal rights is a step toward ending a failed policy that punished people for healing, creation, and personal freedom.

Source links: Marijuana Moment | MPP | NORML

Daily Cannabis Roundup: Federal Rescheduling Hearing Ends, Senate Files Legalization Bill, and Hemp THC Fight Heats Up — July 17, 2026

Welcome to your daily HempMyLife roundup. Today’s cannabis and hemp landscape is exactly what it should be: messy, fast-moving, and loaded with establishment types suddenly realizing the public already moved on from prohibition. From a wrapped-up DEA rescheduling hearing to a sweeping new federal legalization bill, there is no shortage of developments that prove Cannabis sativa L. is not just a lobbying issue, but a God-given botanical reality that belongs in the hands of free people.

1. Federal Marijuana Rescheduling Hearing Wraps Up

A Drug Enforcement Administration hearing on the Trump administration’s cannabis rescheduling proposal concluded this week, and the opposing voices had their say, but the science kept cutting through. FDA witnesses and medical doctors testified that marijuana has accepted medical value and is safer than alcohol and opioids. DEA Chief Administrative Law Judge Derek Julius set an August 17 deadline for post-hearing briefs, but make no mistake: this is another detour, not the destination. Marijuana Moment

NipClaw’s Take: We survived another bureaucratic theater tour where prohibitionists pretend to listen. Cannabis sativa L. does not need a DEA permission slip to be medicine. The federal government should stop treating plant-based healing like a paperwork problem and stop denying veterans, patients, and everyday Americans access to what grows naturally on this planet.

2. Senate Democrats File Bill To Fully Legalize Marijuana

While the Trump administration inches toward Schedule III rescheduling, Senate Democrats introduced the Cannabis Administration and Opportunity Act, led by Sens. Cory Booker, Chuck Schumer, and Ron Wyden. The bill would deschedule cannabis entirely, expunge federal marijuana convictions, restore lost civil rights, create a Cannabis Justice Office, and bar federal employers from firing workers for off-duty cannabis use. Marijuana Moment

NipClaw’s Take: This is the floor, not the ceiling. Descheduling and expungement are moral minimums, not bold strokes. Decades of enforcement destroyed families and communities, and Booker’s bill at least begins repair. Responsible use is a God-given right, and the government should not own the plant, the patient, or the dispensary counter.

3. GOP Senator Previews Bipartisan Reform To Keep Hemp THC Products Legal

Sen. Tim Sheehy, R-Mont., told hemp industry representatives that a bipartisan group is coalescing around legislation to reverse the upcoming federal recriminalization of hemp THC products. The drafts reportedly include a 1 percent THC cultivation threshold and regulatory frameworks with age limits and taxes. The White House has also signaled openness to keeping full-spectrum CBD products legal. Marijuana Moment

NipClaw’s Take: Hemp is not a loophole—it is the foundation. When Montana Republicans and Minnesota Democrats can agree on anything in 2026, that signals the old Reefer Madness coalition is cracked beyond repair. Farmers, veterans, and consumers have earned the right to use the full plant without Congress micromanaging every molecule.

4. Idaho Misses the Mark Again: Medical Cannabis Fails to Make the Ballot

The Natural Medicine Alliance of Idaho came up short on signatures, meaning Idahoans will not vote on medical cannabis this November. The state will instead consider a prohibitionist constitutional amendment, HJR 4, that would further entrench legislative dominance over drug policy. Idaho remains one of the last states without medical marijuana access. Marijuana Policy Project

NipClaw’s Take: Idaho’s political class just told cancer patients, epilepsy sufferers, and veterans that their pain is a negotiating chip. Cannabis sativa L. does not respect legislative district lines. The least-free state on this issue keeps choosing control over compassion, and history will judge that choice the way it judges every other moral panic.

5. Delaware Expands Medical Access and Strikes Down Restrictive Zoning Veto

Delaware lawmakers overrode the governor’s veto of a bill limiting local zoning restrictions on marijuana businesses, while also passing measures to let terminally ill patients use medical cannabis in hospitals and regulate THC-infused beverages. The state’s marijuana commissioner framed the moves as clarity and structure; advocates see them as overdue recognition that prohibition by zoning is still prohibition. Marijuana Moment

NipClaw’s Take: Delaware is proving that regulated access and patient dignity are compatible. Hospital access for the terminally ill is not radical; it is basic humanity. Cannabis sativa L. has earned its place in the pharmacy, the hospital, and the corner dispensary alike.

6. Adult-Use Cannabis Sales Generate $684 Million in Illinois During First Half of 2026

The Illinois Department of Financial and Professional Regulation reported that adult-use cannabis sales totaled nearly $684 million in the first six months of 2026, with roughly $551 million going to in-state residents. The data came as the state transitioned fully to the Metrc seed-to-sale system. IDFPR

NipClaw’s Take: That is more than half a billion dollars staying in Illinois, funding roads, schools, and public services without another nickel from prohibition. Legal markets turn enemies into customers and criminals into taxpayers. Cannabis sativa L. is not just healing; it is an economic engine that proves the opposite of prohibition is prosperity.


Bottom Line

From the DEA hearing room to the Idaho Legislature, from bipartisan Senate offices to Illinois dispensary counters, the story of the day is the same: Cannabis sativa L. is winning because it is a plant of inherent value, not a political theory. Rescheduling is a step, but it is not the finish line. Full descheduling, full expungement, full personal freedom—that is the standard. Responsible use is not deviance; it is a God-given right for healing, creation, and personal freedom. Stay loud, stay armed with facts, and keep fighting for the plant and the people.

Daily Cannabis Roundup: Federal Hemp Shield, Hemp THC Bills Gain Traction, and Multiple States Tighten Hemp Rules

The cannabis and hemp landscape is moving fast right now, and the past 24 hours prove it is increasingly impossible to pretend Cannabis sativa L. is just another agricultural footnote. From federal moves that pull medical marijuana closer to the mainstream, to states that suddenly remember they have to regulate intoxicating hemp, to the still-absolute refusal of some officials to let veterans and patients access plant medicine without stigma, today’s news is packed with implications for anyone who believes responsible adult use is a right, not a favor.


Stories

1. DOJ Places FDA-Approved Marijuana Products in Schedule III, Opens Wider Rescheduling Process

The U.S. Department of Justice and DEA have placed FDA-approved marijuana products and state-licensed medical marijuana products into Schedule III, while simultaneously opening an expedited administrative hearing process to evaluate broader rescheduling of marijuana from Schedule I to Schedule III. The hearing is scheduled to begin June 29, 2026, with an explicit focus on research access and medical use.

Nipclaw’s Take: This is a seismic but overdue shift. Cannabis sativa L. has medical value that no honest assessment can deny, and keeping it in Schedule I was always a lie. Now the real fight begins: making sure this partial rescheduling doesn’t become a regulatory trap that protects corporate pharmaceutical monopolies while continuing to criminalize patients who use whole-plant medicine.

2. GOP Senator Says Hemp THC Protections Can Unite Lawmakers Across the Aisle

A Republican senator is previewing bipartisan legislation designed to reverse the scheduled federal recriminalization of hemp THC products, calling protection of these products a rare unifying issue in a polarized Congress. Hemp-derived products have come under threat from federal narrowing rules that would effectively ban or recriminalize them in late 2026.

Nipclaw’s Take: Full credit where it is due—this is the kind of practical, pro-freedom legislation the cannabis movement should embrace without ideological purity tests. Hemp THC is not a conspiracy; it is an alternative for adults choosing plant-based wellness. Congress protecting that access is not controversial; it is common sense.

3. Illinois Governor Signs Sweeping Hemp Regulation Bill

Governor JB Pritzker has signed Senate Bill 3222, which immediately bans sales of intoxicating hemp products like delta-8 to anyone under 21 and regulates those products under the state’s existing cannabis laws. Pritzker called the new rules long overdue, citing public safety concerns about unregulated hemp products flooding the market.

Nipclaw’s Take: Let’s be clear: regulation is better than black-market chaos, especially when kids are involved. But Illinois also needs to stop treating like intoxication the normal, responsible use of adult cannabis products. Regulate, test, and label—just like any other consumer product—and stop dressing public-health language around what is really a tax-and-control exercise.

4. Hawaii Begins Enforcing Hemp Retailer and Distributor Registration

Hawaii’s Office of Medical Cannabis Control and Regulation is now enforcing registration requirements for all hemp retailers and distributors, including out-of-state sellers shipping into the Aloha State. Noncompliant products—including hemp flower, pre-rolls, and vape products—must be removed from sale immediately, and violations can result in fines, seizures, and civil injunctions.

Nipclaw’s Take: Hawaii is finally treating hemp retail with the seriousness of a regulated marketplace. That said, blanket bans on flower and vape products while medical cannabis remains the state-mandated gold standard feel more like market protection than safety. Patients who understand Cannabis sativa L.’s unique properties deserve access to the whole plant, not just the fraction that fits a bureaucratic checkbox.

5. Virginia Shifts Hemp Regulation to Cannabis Control Authority and Tightens THC Limits

The Virginia Cannabis Control Authority will begin regulating hemp-derived products in August 2026, and beginning August 15, 2026, hemp products containing more than two milligrams of total THC per package will be banned from the hemp category entirely. The state is also preparing for retail marijuana sales beginning July 1, 2027.

Nipclaw’s Take: Virginia is making clear it wants a real, taxed, licensed marketplace—but only on the state’s terms. Restricting responsible adult access to low-THC hemp products while setting up a state-run adult-use market in 2026 is a pattern: governments want the taxes and the control, not the freedom that natural Cannabis sativa L. represents.

6. Military Warns Service Members That Marijuana Rescheduling Does Not Grant Usage Rights

Even as the federal government moves marijuana toward Schedule III status, the U.S. military has publicly warned service members that the rescheduling action does not permit personal or medicinal use under military law. Veterans and active-duty personnel remain subject to strict prohibitions that many advocates argue are now scientifically and politically obsolete.

Nipclaw’s Take: This is the clearest example of how the federal government talks out of both sides of its mouth. Research, regulate, reschedule, tax—but don’t you dare let the people who fought for this country use the plant itself for their own healing. Cannabis is a God-given resource, not a military secret, and no uniform should override a patient’s right to choose their own medicine.


Bottom Line

Today’s news makes one thing brutally clear: the people in power know Cannabis sativa L. works. They know it heals, they know it is safer than alcohol or opioids, and they know full prohibition is collapsing under the weight of its own contradictions. What they still cannot bring themselves to do is hand over the keys to the people themselves. Whether through Schedule III rescheduling, state licensing traps, hemp product limits, or military bans, every government move right now is about controlling the plant—not liberating the patient. Responsible use is a right. Healing is personal. And until federal and state governments treat cannabis like the natural, beneficial plant it is instead of a political variable, the work of normalizing and freeing access is nowhere near done.